This inventor holds 5 USPTO granted patents and 3 published patent applications, plus 2 CIPO patents and 5 EPO patents. Top assignees: Glaxosmithkline Biologicals Sa, Glaxosmithkline LLC. Active years: 2016-2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2016-2021
Title: Inventor Spotlight - Marianne Dewerchin from Rixensart, BE
Introduction:
Meet Marianne Dewerchin, a talented inventor hailing from Rixensart, Belgium, with a total of 5 patents to his name. His innovative contributions have centered around groundbreaking developments in the field of immunogenic compositions and vaccines.
Latest Patents:
Marianne Dewerchin's most recent patents include the pioneering work on UspA2 protein constructs and their versatile applications. These inventions involve compositions incorporating Ubiquitous surface protein A2 (UspA2), along with immunogenic compositions, vaccines, and therapeutic uses thereof. The inclusion of UspA2 in combination with other antigens further enhances the efficacy of these innovative compositions.
Career Highlights:
Throughout his career, Marianne Dewerchin has made significant contributions to the field of biotechnology and pharmaceuticals. He has worked with esteemed companies such as GlaxoSmithKline Biologicals SA and GlaxoSmithKline LLC, where his expertise and dedication have further propelled advancements in vaccine development and therapeutic interventions.
Collaborations:
Collaboration plays a crucial role in driving innovation forward, and Marianne Dewerchin has had the privilege of working alongside notable peers in the industry. Notable coworkers include Normand Blais and Cindy Castado, who have collectively contributed to the success of various projects and patents under his leadership.
Conclusion:
In conclusion, Marianne Dewerchin stands as a beacon of innovation in the realm of biotechnology and pharmaceuticals. His groundbreaking work on UspA2 protein constructs and immunogenic compositions underscores his commitment to advancing healthcare solutions. We look forward to witnessing more groundbreaking inventions from this visionary inventor in the future.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile